Clinical

Dataset Information

0

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors


ABSTRACT: This is a Phase 1 multi-center study to assess the safety and efficacy of TGR-1202 as a single agent or in combination with nab-paclitaxel + gemcitabine or with FOLFOX in patients with select relapsed or refractory solid tumors.

DISEASE(S): Gastrointestinal Stromal Tumor (gist),Colorectal Cancer,Gastric Cancer,Esophageal Cancer,Pancreatic Cancer,Rectal Cancer,Gastrointestinal Stromal Tumors

PROVIDER: 2200015 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2019-05-31 | GSE131762 | GEO
2023-06-22 | GSE223463 | GEO
| 2273237 | ecrin-mdr-crc
2023-07-05 | PXD042267 | Pride
2024-03-21 | GSE262149 | GEO
2024-06-01 | GSE262746 | GEO
| PRJNA544707 | ENA
2021-09-10 | PXD024548 | Pride
2019-06-19 | PXD010112 | Pride
2023-10-19 | GSE241876 | GEO